Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMS-D001 in Moderate to Severe Plaque Psoriasis
NCT07432854Phase 3Not yet recruiting
- Sponsor
- Dermavant Sciences
- Start
- Mar 2026
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CMS-D001 in plaque psoriasis, sponsored by Dermavant Sciences. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
CMS-D001
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07432854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07432854.